Osteoarthritis (OA) is the most common form of arthritis and the leading cause of musculoskeletal disability worldwide, affecting more than 32.5 million adults in the United States. It is a degenerative joint disease driven by the breakdown and eventual loss of articular cartilage, accompanied by structural changes in the underlying bone. Unlike rheumatoid arthritis — which is an autoimmune condition — OA results from mechanical wear, chondrocyte dysfunction, and low-grade local inflammation. Nurses encounter OA across every care setting: primary care, orthopedics, long-term care, surgical units, and rehabilitation. Understanding its pathophysiology, clinical presentation, pharmacologic options, and functional impact is essential for managing pain, preventing disability, and safely supporting patients through joint replacement surgery.
Fast-scan summary: key osteoarthritis facts
| Parameter | Key facts |
|---|---|
| Type | Degenerative joint disease (non-autoimmune); primary (idiopathic) or secondary (post-injury, obesity, metabolic) |
| Affected joints | Weight-bearing and high-use joints: knees, hips, hands (DIP, PIP), spine (facets), first MTP joint; asymmetric distribution |
| Pathophysiology hallmark | Cartilage degradation via MMP and ADAMTS enzyme activity → joint space narrowing, osteophyte formation, subchondral sclerosis |
| Pain characteristic | Worsens with activity, relieved by rest; worse at end of day (opposite of RA which improves with activity) |
| Morning stiffness | Brief — typically less than 30 minutes (RA morning stiffness lasts more than 1 hour — key NCLEX distinction) |
| Key labs | ESR and CRP normal or only mildly elevated; RF negative; helps differentiate from RA |
| First-line pharmacology | Acetaminophen (mild-moderate pain); NSAIDs (second-line); topical diclofenac for localized joint OA |
| Key nursing priorities | Pain management, mobility preservation, weight management, fall prevention, patient education, ADL support |
| Definitive treatment (severe) | Total joint replacement (TJR) — knee or hip arthroplasty |
| Epidemiology | Prevalence rises sharply after age 45; women affected more than men, especially post-menopause; obesity is a major modifiable risk factor |
Pathophysiology
Cartilage and chondrocyte dysfunction
Articular cartilage is maintained by chondrocytes, specialized cells that regulate the balance between synthesis and degradation of the extracellular matrix (ECM). The ECM is composed primarily of type II collagen (providing tensile strength) and proteoglycans such as aggrecan (providing compressive resistance). In healthy joints, chondrocytes maintain this matrix in a state of dynamic equilibrium.
In OA, that equilibrium breaks down. Mechanical stress, aging, obesity, prior joint injury, and metabolic factors shift chondrocyte behavior toward a predominantly catabolic state. Chondrocytes begin overproducing pro-inflammatory cytokines — particularly interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α) — which then stimulate the release of matrix metalloproteinases (MMPs) and ADAMTS enzymes (a disintegrin and metalloproteinase with thrombospondin motifs). These enzymes directly degrade collagen and aggrecan, progressively eroding cartilage from the articular surface inward.
As cartilage thins, the underlying subchondral bone is exposed to greater mechanical load. The bone responds by thickening and remodeling — a process called subchondral sclerosis — which makes the bone stiffer and less able to absorb impact, further accelerating cartilage loss. Marginal osteophytes (bone spurs) form at the joint edges as the periosteum attempts to stabilize the joint. These bony projections restrict range of motion and can impinge on adjacent soft tissue, contributing to pain.
Role of low-grade inflammation
Although OA is classified as a degenerative rather than inflammatory arthritis, synovial inflammation does occur — particularly in advanced disease. Cartilage fragments shed into the joint space activate synoviocytes, triggering synovial fluid changes and intermittent joint effusion. This low-grade synovitis amplifies pain and accelerates matrix degradation, though it does not produce the degree of systemic inflammation seen in rheumatoid arthritis.
Summary of structural changes
The cardinal structural changes in OA are:
- Cartilage loss — progressive thinning and eventual full-thickness erosion
- Subchondral sclerosis — bone thickening beneath the cartilage surface
- Subchondral cysts — fluid-filled cavities in subchondral bone, formed by intrusion of synovial fluid through cartilage defects
- Osteophytes — marginal bony spurs at joint edges
- Joint space narrowing — visible on plain radiographs; the clinical-radiographic hallmark of OA
OA vs RA comparison
Understanding the distinction between osteoarthritis and rheumatoid arthritis is a high-yield NCLEX topic. The two conditions differ fundamentally in mechanism, joint distribution, systemic features, and treatment approach.
| Feature | Osteoarthritis (OA) | Rheumatoid arthritis (RA) |
|---|---|---|
| Type | Degenerative (wear-and-tear) | Autoimmune inflammatory |
| Onset | Gradual; usually after age 45 | Any age (peak 30–50 years); can be acute |
| Joint distribution | Asymmetric; weight-bearing joints, DIP, PIP, first MTP | Symmetric; MCP, PIP, wrists, MTP; DIP spared |
| Morning stiffness | Less than 30 minutes | More than 1 hour (hallmark) |
| Pain pattern | Worsens with activity; relieved by rest | Improves with activity; worse after inactivity |
| Systemic features | Absent | Present: fatigue, weight loss, low-grade fever, extra-articular manifestations |
| Hand nodes | Heberden's nodes (DIP), Bouchard's nodes (PIP) | No nodes; swan-neck deformity, boutonnière deformity |
| Inflammation markers | ESR/CRP normal or mildly elevated; RF negative | Elevated ESR, CRP; RF positive (~70–80%); anti-CCP positive (~95%) |
| X-ray findings | Joint space narrowing, osteophytes, subchondral sclerosis, subchondral cysts; no erosions | Periarticular osteopenia, joint erosions, symmetric joint space narrowing |
| Treatment | Acetaminophen, NSAIDs, PT, weight management, joint replacement | DMARDs (methotrexate first-line), biologics, corticosteroids |
Clinical presentation
Symptom pattern
OA presents with joint pain that is activity-related — characteristically worsening with use and relieved by rest. Patients often describe the pain as a deep, aching discomfort localized to the affected joint. In advanced disease, rest pain and night pain can occur, but these are less prominent than in inflammatory arthritis.
Morning stiffness in OA is brief — typically less than 30 minutes — and is often described as a “gelling” sensation after rest periods. This brief stiffness contrasts sharply with RA, where morning stiffness characteristically exceeds one hour and responds to activity. This distinction is a common NCLEX question stem.
As disease progresses, patients develop:
- Crepitus — a palpable or audible crackling sensation with joint movement, caused by irregularity of the articular surfaces
- Joint tenderness on palpation at the joint line
- Bony enlargement — hard, non-tender swelling from osteophytes
- Decreased range of motion — progressive limitation due to structural changes and muscle splinting
- Joint effusion — particularly common in knee OA; soft, fluctuant swelling representing excess synovial fluid
Joint distribution
OA preferentially affects weight-bearing and high-use joints:
| Joint | Clinical features | Functional impact |
|---|---|---|
| Knees | Most commonly affected; medial compartment predominates; varus (bow-leg) deformity in advanced disease; crepitus prominent | Difficulty with stairs, squatting, prolonged walking; fall risk |
| Hips | Groin pain, reduced internal rotation; antalgic gait; pain referred to thigh or knee | Impaired gait, difficulty with shoe/sock donning, transfers |
| Hands (DIP) | Heberden's nodes — bony enlargements at distal interphalangeal joints; lateral deviation possible | Impaired fine motor tasks: buttoning, writing, jar-opening |
| Hands (PIP) | Bouchard's nodes — bony enlargements at proximal interphalangeal joints | Similar fine motor impairment; cosmetic distress common |
| Spine (facets) | Cervical and lumbar involvement; osteophytes can impinge on nerve roots → radiculopathy | Neck/low back pain, reduced spinal mobility, neurologic symptoms if nerve root involved |
| First MTP (great toe) | Hallux rigidus; stiffness and pain on toe dorsiflexion | Altered gait mechanics, difficulty with footwear |
Heberden’s nodes vs Bouchard’s nodes — NCLEX key point: Both are bony, hard enlargements caused by osteophyte formation in hand OA. Heberden’s nodes occur at DIP joints; Bouchard’s nodes at PIP joints. Neither is associated with RA, which spares the DIP joints. Confusing these two is a classic exam distractor.
Diagnosis and staging
Diagnostic approach
OA is primarily a clinical diagnosis, supported by radiographic findings. No blood test confirms OA. The diagnostic approach involves:
- History and physical exam — symptom pattern (activity-related pain, brief morning stiffness), joint distribution, bony enlargement, crepitus, reduced ROM
- Plain radiographs (X-ray) — standard imaging; MRI is not routinely required but can identify soft tissue changes and early cartilage loss before X-ray changes appear
- Laboratory tests — used to exclude inflammatory arthritis, not to confirm OA
X-ray findings in OA
The four cardinal radiographic features of OA are:
- Joint space narrowing — reflects cartilage loss; most important X-ray finding
- Osteophytes — bony spurs at joint margins
- Subchondral sclerosis — increased bone density beneath the cartilage; appears whiter/denser on X-ray
- Subchondral cysts — lucent (dark) areas in subchondral bone; formed by fluid intrusion through cartilage defects
Absence of erosions on X-ray is a key distinguishing feature from RA. Erosions characterize inflammatory arthritis; OA produces bony proliferation (spurs), not erosion.
Kellgren-Lawrence grading scale
The Kellgren-Lawrence (KL) scale is the standard radiographic grading system for OA severity, scored 0–4:
| Grade | Radiographic findings | Clinical correlation |
|---|---|---|
| Grade 0 | No OA features | Normal joint |
| Grade 1 | Doubtful joint space narrowing; possible osteophytic lipping | Doubtful OA; symptoms may be absent or minimal |
| Grade 2 | Definite osteophytes; possible joint space narrowing | Mild OA; symptoms typically present |
| Grade 3 | Multiple osteophytes; definite joint space narrowing; subchondral sclerosis; possible bone end deformity | Moderate OA; significant functional limitation |
| Grade 4 | Large osteophytes; marked joint space narrowing; severe sclerosis; definite bone end deformity | Severe OA; major disability; candidate for joint replacement |
Laboratory findings
Laboratory tests in OA are typically normal or near-normal, which is diagnostically useful:
- ESR and CRP: Normal or only mildly elevated. Significantly elevated inflammatory markers should prompt evaluation for RA or another inflammatory arthritis.
- Rheumatoid factor (RF): Negative in OA (positive in ~70–80% of RA patients)
- Anti-CCP antibodies: Negative in OA (highly specific for RA when positive)
- Synovial fluid analysis (if aspirated): Noninflammatory — WBC count less than 2,000 cells/mm³, predominantly mononuclear cells; contrasts with RA (2,000–50,000 cells/mm³) and septic arthritis (more than 50,000 cells/mm³)
Nursing assessment
Comprehensive nursing assessment of the patient with OA addresses pain, functional status, fall risk, and psychosocial impact.
Assessment framework
| Assessment domain | What to assess | Tools / normal vs abnormal |
|---|---|---|
| Pain | Location, character, severity, timing (activity vs rest), aggravating and relieving factors, impact on sleep | 0–10 numeric rating scale or VAS; WOMAC pain subscale for knee/hip OA; abnormal: pain ≥4/10 impairing function |
| Functional status | ADL and IADL performance: dressing, bathing, grooming, transfers, ambulation, stair climbing, household tasks | WOMAC functional subscale; Barthel Index; abnormal: dependence in any ADL directly attributable to joint pain or stiffness |
| Mobility and gait | Gait pattern (antalgic, Trendelenburg), assistive device use, range of motion, crepitus, joint effusion | Observe gait; measure ROM (goniometer); abnormal: antalgic gait, limping, measurable ROM reduction, visible effusion |
| Fall risk | History of falls, balance, muscle strength (especially quadriceps for knee OA), footwear, home hazards | Morse Fall Scale or Hendrich II; Timed Up and Go (TUG) test; abnormal: TUG >12 seconds suggests fall risk |
| Weight and BMI | Current weight, BMI, weight trajectory; obesity directly worsens knee and hip OA load | BMI; abnormal: BMI >25 kg/m² indicates excess joint loading; every 1 lb lost reduces knee joint load by ~4 lbs |
| Psychosocial | Depression and anxiety screening (OA strongly associated with depression), social support, impact on work and leisure, coping strategies | PHQ-2 or PHQ-9 for depression screening; abnormal: PHQ-9 score ≥10 indicates moderate depression requiring intervention |
| Medication history | Current analgesics, OTC NSAID use, supplements; renal and hepatic function; GI history (NSAID risk); alcohol use (acetaminophen safety) | Review medication list; abnormal: concurrent alcohol use with acetaminophen, unmonitored long-term NSAID use without GI protection |
| Knowledge and self-management | Understanding of OA, treatment goals, activity pacing, weight management; adherence to home exercise program | Open-ended questioning; abnormal: misconceptions about exercise being harmful (a very common patient barrier) |
WOMAC scale
The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is the gold-standard patient-reported outcome measure for knee and hip OA. It assesses three domains:
- Pain (5 items)
- Stiffness (2 items)
- Physical function (17 items)
Higher scores indicate worse symptoms. WOMAC is widely used in clinical trials and is a validated endpoint for tracking OA treatment response. For more on structured patient assessment, see the head-to-toe assessment guide.
Nursing diagnoses
The top NANDA-aligned nursing diagnoses for OA address pain, mobility, and the functional and psychosocial consequences of chronic joint disease.
-
Chronic pain related to cartilage loss, bone-on-bone joint changes, and osteophyte formation, evidenced by patient-reported joint pain rated ≥4/10, activity-related guarding, and disturbed sleep.
-
Impaired physical mobility related to joint pain, decreased range of motion, and muscle weakness, evidenced by limited ROM on examination, antalgic gait, and self-reported difficulty with ADLs.
-
Risk for falls related to joint pain, altered gait mechanics, muscle weakness, and assistive device unfamiliarity, evidenced by fall history, positive TUG test, or Morse Fall Scale score ≥45.
-
Activity intolerance related to pain with exertion, deconditioning, and fear of movement (kinesiophobia), evidenced by patient avoidance of physical activity and reports of excessive fatigue with minimal exertion.
-
Deficient knowledge regarding OA management, exercise benefits, weight management, joint protection techniques, and medication use, evidenced by patient misconceptions about activity being harmful or expressed inability to describe self-management strategies.
Nursing interventions
Pain management
| Intervention | Details and nursing considerations |
|---|---|
| Acetaminophen (first-line) | First-line pharmacologic agent for mild-to-moderate OA pain. Maximum 3,000 mg/day in older adults; 4,000 mg/day in healthy adults. Counsel patients to avoid concurrent alcohol use (hepatotoxicity risk). Monitor liver function in long-term users. Preferred over NSAIDs in older adults due to lower GI and cardiovascular risk. |
| Oral NSAIDs (second-line) | Ibuprofen, naproxen, celecoxib. Use lowest effective dose for shortest duration. Monitor for GI bleeding, renal impairment, and cardiovascular effects. Add proton pump inhibitor (PPI) for patients at GI risk (age >65, history of peptic ulcer disease, concurrent anticoagulant use). Celecoxib (COX-2 selective) has lower GI risk but similar cardiovascular risk to nonselective NSAIDs. Avoid or use with extreme caution in patients with CKD — see the [acute kidney injury nursing reference](/nursing-tips/aki-nursing-reference/) for renal considerations. |
| Topical diclofenac | Topical NSAID gel applied directly to affected joint (particularly knee and hand OA). Lower systemic absorption than oral NSAIDs — preferred option when GI or renal concerns limit oral NSAID use. Apply 4 times daily to affected joint; avoid open wounds. |
| Duloxetine (Cymbalta) | Serotonin-norepinephrine reuptake inhibitor (SNRI); FDA-approved for chronic musculoskeletal pain including OA. Useful when patients have comorbid depression or when other analgesics are insufficient. Monitor for serotonin syndrome if combined with other serotonergic agents. |
| Intra-articular corticosteroids | Injected directly into affected joint (commonly knee, hip, shoulder). Effective for short-term pain relief (weeks to months) during flares. Limit to 3–4 injections per joint per year — repeated injections may accelerate cartilage loss. Monitor for transient blood glucose elevation in patients with [diabetes](/nursing-tips/diabetes-mellitus-nursing/). |
| Intra-articular hyaluronic acid (viscosupplementation) | Injection of synthetic hyaluronic acid into the joint to restore lubrication. Evidence is mixed — benefits over placebo are modest. More commonly used for knee OA when patients are not surgical candidates. Not recommended as routine first-line injection therapy by AAOS guidelines. |
| Heat therapy | Moist heat (warm compresses, paraffin baths for hand OA) reduces muscle spasm and stiffness; best used before activity or exercise. Avoid over areas with acute effusion. |
| Cold therapy | Ice packs applied after activity or during flares reduce swelling and acute pain; apply 15–20 minutes with cloth barrier. Preferred over heat when joint is acutely inflamed or swollen. |
| TENS (transcutaneous electrical nerve stimulation) | Non-pharmacologic adjunct; may reduce pain perception via gate control mechanism. Applied to skin over affected joint. Evidence is limited but some patients find benefit; minimal risk profile. |
| Opioid analgesics | Reserved for patients with severe OA pain when other interventions have failed and surgery is not an option. Use cautiously — significant risks of dependence, falls, cognitive impairment in older adults. Use lowest effective dose for shortest duration. Tramadol may be considered as a weak opioid option; avoid strong opioids as routine OA treatment. |
Mobility and exercise interventions
Exercise is one of the most evidence-based treatments for OA. Patients commonly believe that activity will worsen their joints — correcting this misconception is a core nursing education priority.
| Intervention | Details and nursing considerations |
|---|---|
| Physical therapy referral | First-line non-pharmacologic intervention. PT provides strengthening exercises (particularly quadriceps for knee OA), ROM exercises, gait training, and functional rehabilitation. Coordinate referral; reinforce home exercise program adherence. |
| Aquatic therapy | Exercise in warm water reduces joint loading while providing resistance for strengthening. Ideal for patients with moderate-to-severe OA who cannot tolerate land-based exercise. Buoyancy reduces weight-bearing stress on knees and hips by up to 90%. |
| Low-impact aerobic exercise | Walking, cycling, swimming, and water aerobics. Cardiovascular fitness reduces overall disability and improves pain tolerance. Encourage at least 150 minutes/week of moderate-intensity activity (consistent with [diabetes management guidelines](/nursing-tips/diabetes-mellitus-nursing/) that overlap in OA patients with metabolic comorbidities). |
| Strengthening exercises | Quadriceps strengthening is particularly important for knee OA — strong quadriceps reduces load on the medial compartment. Resistance band exercises, isometric exercises, and leg press are appropriate. Start with low resistance and progress gradually. |
| Assistive devices | Canes, walkers, crutches, and knee braces can reduce joint loading and improve stability. A cane used in the contralateral hand (opposite side from affected knee/hip) reduces ipsilateral joint load by up to 50%. Ensure proper device fitting; refer to occupational therapy for ADL adaptations and adaptive equipment (jar openers, long-handled reachers, grab bars). |
| Joint protection techniques | Teach patients to: use larger joints for tasks when possible (push a door with forearm rather than fingers), avoid positions that stress affected joints, use ergonomic tools, take rest breaks, and avoid prolonged static joint positions. |
| Orthotics and footwear | Lateral wedge insoles may reduce medial knee compartment load in varus knee OA. Cushioned, supportive footwear reduces impact forces. Assess footwear at every visit — inappropriate footwear is a modifiable fall risk factor. |
Weight management
Weight management is arguably the most impactful modifiable intervention for knee and hip OA. The biomechanical relationship between body weight and joint loading is significant:
- Every 1 lb of body weight lost = approximately 4 lbs less knee joint load during walking (due to lever arm mechanics)
- A 10 lb weight loss reduces knee joint load by roughly 40 lbs per step
- Weight loss of 5–10% body weight produces clinically significant improvements in pain and function
Nursing role in weight management includes:
- Assessing BMI and weight history at every visit
- Exploring patient readiness for lifestyle change using motivational interviewing
- Providing dietary counseling referral or coordinating with a registered dietitian
- Reinforcing that even modest weight loss has measurable joint benefit
- Addressing barriers: depression, limited mobility, pain with exercise (treat pain first so exercise becomes possible)
For patients with OA and comorbid diabetes mellitus, weight management addresses both conditions simultaneously.
Fall prevention
Patients with OA — particularly knee and hip OA — have elevated fall risk due to pain-related gait alteration, muscle weakness, and reduced proprioception. Falls are a leading cause of serious injury in older adults and a primary driver of nursing home placement. For detailed fall prevention protocols, the head-to-toe assessment framework includes gait and fall risk components.
Fall prevention interventions specific to OA:
- Conduct formal fall risk assessment at every encounter (Morse Fall Scale; Hendrich II)
- Ensure appropriate assistive device use and patient education on correct technique
- Refer to PT for balance and gait training
- Assess home environment: remove throw rugs, ensure good lighting, install grab bars in bathroom
- Review medications for fall risk contributors: opioids, benzodiazepines, antihypertensives, anticholinergics
- Ensure adequate pain control — undertreated pain causes protective gait patterns that increase fall risk
- Monitor for DVT post-operatively in surgical OA patients (prolonged immobility is a risk factor)
Surgical management
Surgery is indicated when conservative management fails to provide adequate pain relief or functional improvement, and when OA severity significantly impairs quality of life.
Total joint replacement (arthroplasty)
Total knee replacement (TKR) and total hip replacement (THR) are among the most commonly performed and successful elective surgical procedures. They are the definitive treatment for end-stage (KL Grade 3–4) OA.
Indications:
- Severe OA with inadequate response to 3–6 months of conservative therapy
- Pain interfering significantly with sleep, ADLs, or quality of life
- KL Grade 3–4 radiographic changes with functional limitation
Preoperative nursing care:
- Complete preoperative assessment including cardiopulmonary fitness (surgical clearance)
- Anticoagulation review — patients on warfarin, aspirin, or antiplatelet agents require bridging plans
- Blood glucose optimization in patients with diabetes mellitus (hyperglycemia increases surgical infection risk)
- Patient education: expected recovery timeline, deep breathing exercises, anticoagulation plan, weight-bearing restrictions, precautions (hip replacement posterior approach precautions: no flexion >90°, no internal rotation, no adduction past midline)
- Prehabilitation: preoperative strengthening and conditioning shown to improve postoperative recovery
Postoperative nursing care:
- Pain management: multimodal analgesia (acetaminophen + NSAIDs + local nerve blocks); minimize opioid use
- VTE prophylaxis: DVT prevention is a mandatory post-arthroplasty priority — sequential compression devices (SCDs), early ambulation, pharmacologic anticoagulation (LMWH, aspirin, or direct oral anticoagulants per protocol)
- Early mobilization: ambulate day of or day 1 post-surgery; early weight-bearing is typically encouraged for cemented implants
- Wound assessment: monitor surgical incision for signs of infection (erythema, warmth, purulent drainage, fever)
- Hip precautions (posterior approach THR): enforce flexion <90°, no internal rotation, no crossing legs/adduction; these precautions prevent prosthetic dislocation
- Monitor for complications: pulmonary embolism, infection, dislocation (hip), neurovascular compromise (assess circulation, sensation, and movement distally)
- Discharge planning: home PT, assistive devices, raised toilet seat for hip replacement, follow-up scheduling
Osteotomy
Realignment surgery that redistributes joint load away from the most damaged compartment. Used in younger patients with unicompartmental OA who wish to delay total joint replacement. Less commonly performed than arthroplasty.
Arthroscopy
Arthroscopic lavage and debridement of the OA joint is no longer recommended as a standard treatment — multiple randomized controlled trials have shown it provides no benefit over sham surgery for OA-related pain. Mention in nursing education as a historically performed but now discouraged procedure.
Patient education
Patient education is a cornerstone of OA management. Self-management programs and structured education have demonstrated improved pain outcomes and reduced disability.
Key teaching points:
-
OA is manageable, not inevitable decline. Many patients believe OA means they must simply accept worsening disability. Correct this: exercise, weight management, and appropriate treatment can substantially preserve function.
-
Exercise will not “wear out” the joint further. This is the most common patient misconception. Appropriate exercise strengthens the muscles that support the joint, reduces pain over time, and improves function. Avoidance of activity accelerates deconditioning and worsens outcomes.
-
Weight management has a profound impact. Use the 1 lb = 4 lbs knee load reduction ratio — it is a concrete, motivating statistic for patients. Even 5–10 lb weight loss produces measurable functional improvement.
-
Activity pacing. Teach patients to alternate periods of activity with rest, plan energy-intensive tasks for times of day when pain is lower, and use adaptive strategies (sitting rather than standing for tasks where possible).
-
Proper body mechanics. Avoid postures and activities that load damaged joints. Use the largest available joint for a task (slide rather than lift, push with body weight rather than grip strength). Use proper lifting mechanics.
-
Medication safety — acetaminophen. Emphasize the hidden acetaminophen in combination products (cold and flu preparations, prescription combination analgesics). Patients must track total daily acetaminophen from all sources to stay within safe limits.
-
Medication safety — NSAIDs. Advise patients to take with food, report GI symptoms promptly, avoid combining OTC NSAIDs with prescription NSAIDs, and report any changes in urine output or leg swelling (potential renal effects).
-
When to call the provider: New or significantly worsening joint pain, fever with joint pain (possible septic arthritis — a medical emergency), sudden marked swelling, inability to bear weight, signs of medication side effects.
-
Assistive device use. Reinforce correct cane technique: cane in contralateral hand, tip placed 6 inches to the side and 6 inches ahead, elbow slightly flexed. Many patients use canes incorrectly on the same side as the painful joint.
-
Community resources. Arthritis Foundation (arthritis.org) self-management programs (Arthritis Self-Management Program, Walk With Ease) are evidence-based and widely available.
Complications
Joint deformity and malalignment. Progressive OA leads to structural joint deformity — varus (bow-leg) deformity in knee OA, hip adduction contracture in hip OA. Deformity further alters biomechanics and accelerates joint deterioration.
Functional decline and disability. End-stage OA of weight-bearing joints is one of the leading causes of disability in older adults. Inability to perform ADLs independently leads to loss of community living, increased caregiver burden, and increased healthcare utilization.
Depression and anxiety. Chronic pain is strongly associated with depression. OA patients have significantly higher rates of depression than the general population. Undertreated depression worsens pain perception and reduces motivation for self-management behaviors. Screen at every encounter with PHQ-2 or PHQ-9.
Falls and fractures. Gait instability from OA pain and muscle weakness is a major fall risk factor. Hip fractures in older adults with OA carry high morbidity and mortality. Fall prevention must be an active nursing priority, not a passive consideration. See also osteoporosis nursing — many patients have both OA and osteoporosis, compounding fracture risk.
Opioid dependence. Long-term opioid use for OA pain carries significant risks in older adults: constipation, cognitive impairment, falls, sedation, and physical dependence. Nurses play a key role in advocating for non-opioid pain management strategies and monitoring for signs of opioid overuse.
Sleep disturbance. OA pain frequently disrupts sleep. Poor sleep amplifies pain perception (central sensitization), creating a cycle that worsens both conditions. Address sleep hygiene as part of the OA management plan.
NCLEX-style practice questions
| # | Question | Answer and rationale |
|---|---|---|
| 1 | A 68-year-old patient reports bilateral knee pain that is worst after a long walk and improves with rest. Morning stiffness lasts about 20 minutes. X-rays show joint space narrowing and osteophytes bilaterally. Which condition does this presentation most suggest? A. Rheumatoid arthritis B. Osteoarthritis C. Gout D. Septic arthritis |
B — Osteoarthritis. The activity-related pain pattern (worsens with use, relieved by rest), brief morning stiffness (<30 minutes), older age, bilateral weight-bearing joint involvement, and radiographic osteophytes with joint space narrowing are classic for OA. RA presents with symmetric small joint involvement and morning stiffness >1 hour. Gout is episodic and typically monoarticular. Septic arthritis presents acutely with fever and a single hot, swollen joint. |
| 2 | A nurse is teaching a patient newly diagnosed with knee OA. The patient states, "My doctor wants me to exercise, but won't that just wear my knee out faster?" Which response by the nurse is most appropriate? A. "You should rest your knee as much as possible to protect the cartilage." B. "Appropriate exercise strengthens the muscles supporting your joint and reduces pain over time — it will not accelerate joint damage." C. "High-impact exercise like running is best for rebuilding cartilage." D. "Your concern is valid — exercise does worsen joint damage in most OA patients." |
B is correct. Exercise — particularly low-impact aerobic activity and muscle strengthening — is one of the most evidence-based OA treatments. It does not accelerate cartilage loss. Fear of activity (kinesiophobia) is a common patient barrier that nurses must actively address. Option A reinforces a harmful misconception. Option C is incorrect — high-impact exercise is contraindicated in OA. Option D is factually false. |
| 3 | Which pharmacologic agent is considered first-line for mild-to-moderate osteoarthritis pain in older adults? A. Oral ibuprofen B. Tramadol C. Acetaminophen D. Prednisone |
C — Acetaminophen. Acetaminophen is the preferred initial analgesic for OA in older adults because it has fewer GI and cardiovascular risks than NSAIDs. Oral NSAIDs (such as ibuprofen, option A) are second-line; their GI, renal, and cardiovascular risks make them less ideal as first-line agents in older populations. Tramadol (B) carries fall and cognitive impairment risks in older adults. Oral corticosteroids (D) are not appropriate for chronic OA management — intra-articular corticosteroids may be used for flares. |
| 4 | A nurse is caring for a patient one day after total hip replacement (posterior approach). The patient wants to pick up a dropped item from the floor. Which instruction should the nurse give? A. "Bend forward from the waist to reach the item." B. "Avoid bending your hip past 90 degrees — use a long-handled reacher instead." C. "Cross your operated leg over your other leg to increase your reach." D. "Turn your toes inward when bending to protect the joint." |
B is correct. Posterior approach hip precautions prohibit flexion past 90°, internal rotation, and adduction past midline — all of which risk prosthetic dislocation. Option A (forward bending) would violate the 90° flexion restriction. Option C (crossing legs) violates the adduction precaution. Option D (toes inward) violates the internal rotation precaution. Use of adaptive equipment such as reachers maintains precautions while preserving function. |
| 5 | A nurse is comparing hand findings in OA vs rheumatoid arthritis. Which finding is specific to OA and would NOT be expected in RA? A. Swelling of the proximal interphalangeal (PIP) joints B. Bony enlargement of the distal interphalangeal (DIP) joints C. Symmetric involvement of the metacarpophalangeal (MCP) joints D. Elevated rheumatoid factor (RF) |
B is correct. Heberden's nodes (bony enlargements at DIP joints) are characteristic of OA and are not a feature of RA. RA classically spares the DIP joints. Option A (PIP swelling) can occur in both OA (Bouchard's nodes) and RA. Option C (symmetric MCP involvement) is characteristic of RA, not OA. Option D (elevated RF) is a marker of RA, not OA. |
| 6 | A nurse is teaching a patient with knee OA about cane use. The patient's left knee is affected. Where should the patient hold the cane, and why? A. Left hand, to support the painful knee directly B. Right hand, to reduce load on the left knee through contralateral shifting C. Either hand, as it makes no difference biomechanically D. No cane is needed until the patient has bilateral knee involvement |
B is correct. A cane used in the hand contralateral to the affected joint reduces force on that joint by shifting the center of gravity and reducing the hip abductor muscle demand, decreasing ipsilateral knee/hip loading by up to 50%. Using the cane on the same side as the affected joint (option A) is a common patient error that loses this biomechanical advantage. Option C is incorrect — side of use matters significantly. Option D is incorrect — a cane is indicated for pain and stability regardless of laterality. |
Summary
Osteoarthritis is a degenerative joint disease driven by cartilage breakdown, chondrocyte dysfunction, and secondary bone remodeling. It is the most common form of arthritis and a leading cause of disability in older adults. Key nursing priorities center on pain management (with acetaminophen as first-line pharmacotherapy), mobility preservation through evidence-based exercise, weight management (with its 1:4 joint load reduction ratio), fall prevention, and patient education that corrects the harmful misconception that activity worsens OA.
Distinguishing OA from rheumatoid arthritis remains a high-yield clinical and NCLEX skill: OA is asymmetric, activity-worsens/rest-relieves, short morning stiffness, negative inflammatory markers, produces osteophytes and sclerosis (not erosions), and does not cause systemic illness. For the complete musculoskeletal cluster, see rheumatoid arthritis nursing and osteoporosis nursing.
Reviewed by Lindsay Smith, AGPCNP. Clinical references: NIH NIAMS Osteoarthritis Overview; NCBI StatPearls Osteoarthritis (NBK482326); Arthritis Foundation Clinical Guidance; Kellgren-Lawrence Classification (PMC4925407); American College of Rheumatology OA Guidelines.